Brandon Kashfian

Founder & Chief Business Officer at AltaThera Pharmaceuticals

Brandon Kashfian is an accomplished pharmaceutical industry executive and entrepreneur with over two decades of experience. He is currently the Founder & Chief Business Officer at AltaThera Pharmaceuticals, a commercial-stage specialty pharmaceutical company focused on critical care and alternative therapeutics for patients with severe and rare disorders.1

Career Highlights

Brandon's career trajectory showcases his expertise in both the pharmaceutical and financial sectors:

Pharmaceutical Industry::

Founder & Chief Business Officer at AltaThera Pharmaceuticals (2019-present)1
Founder, President, and CEO of AltaThera Pharmaceuticals (2011-2018)1
Director of Business Development & Licensing at Lundbeck (2009-2011)1
Director of Business Development at Ovation Pharmaceuticals (2003-2009)1

Financial Sector::

Venture Capital Associate at William Blair Capital Partners LLC (2000-2001)1
Investment Banking Associate at J.P. Morgan Chase & Co. (1997-2000)1

Research::

Research Associate in the Division of Medical Oncology, Section of Biochemical Pharmacology at City of Hope (1993-1995)1

Education

Brandon Kashfian's educational background is diverse and impressive:

MBA from The University of Chicago Booth School of Business (2002-2004)1
MS in Neurobiology & Physiology from Northwestern University (2002-2004)1
Attended The University of Chicago Pritzker School of Medicine (1995-1996)1
AB degree as a Phi Beta Kappa scholar from Colby College (1989-1993)1

AltaThera Pharmaceuticals

As the Founder & Chief Business Officer of AltaThera Pharmaceuticals, Brandon leads a company dedicated to addressing unmet medical needs for patients with severe and often rare disorders.1 The company focuses on developing and commercializing critical care and alternative therapeutics in areas where few effective treatments are available.1

Brandon Kashfian's LinkedIn profile (username: brandonkashfian) provides a comprehensive overview of his professional experience and achievements in the pharmaceutical industry.

Experience

Founder & Chief Business Officer at AltaThera Pharmaceuticals (2019 - Present)

Founder, President, CEO at AltaThera Pharmaceuticals (2011 - 2018), - Director, Business Development & Licensing at Lundbeck (2009 - 2011) - Director, Business Development at Ovation Pharmaceuticals (2003 - 2009) - Venture Capital Associate at William Blair Capital Partners LLC (2000 - 2001) - Investment Banking Associate at J.P. Morgan Chase & Co. (First Chicago Capital Markets) (1997 - 2000) - Research Associate, Division of Medical Oncology, Section of Biochemical Pharmacology at City of Hope (1993 - 1995)

Education

- AB, Phi Beta Kappa at Colby College (1989 - 1993) - The University of Chicago Pritzker School of Medicine (1995 - 1996) - MS in Neurobiology & Physiology at Northwestern University (2002 - 2004) - MBA at The University of Chicago Booth School of Business (2002 - 2004)